Fei-Xiang Lin

430 total citations
16 papers, 282 citations indexed

About

Fei-Xiang Lin is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Fei-Xiang Lin has authored 16 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Fei-Xiang Lin's work include Spinal Cord Injury Research (4 papers), Nerve injury and regeneration (3 papers) and Bone Metabolism and Diseases (3 papers). Fei-Xiang Lin is often cited by papers focused on Spinal Cord Injury Research (4 papers), Nerve injury and regeneration (3 papers) and Bone Metabolism and Diseases (3 papers). Fei-Xiang Lin collaborates with scholars based in China. Fei-Xiang Lin's co-authors include Bo-Jui Chang, Xuedong Li, Shi‐xin Du, Da Xie, Dezhong Liu, Guoyong Yu, Qihao Zhang, Peng Xie, Wei He and Shasha Du and has published in prestigious journals such as Experimental Neurology, Journal of Pharmaceutical Sciences and Osteoporosis International.

In The Last Decade

Fei-Xiang Lin

14 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fei-Xiang Lin China	10	144	54	39	31	29	16	282
Mohammad Hadi Farjoo Iran	9	142 1.0×	69 1.3×	27 0.7×	34 1.1×	33 1.1×	13	367
Dianming Jiang China	11	208 1.4×	65 1.2×	38 1.0×	35 1.1×	20 0.7×	16	348
Ruohan Yang China	15	194 1.3×	56 1.0×	78 2.0×	36 1.2×	38 1.3×	29	428
Xiaodi Gong China	10	144 1.0×	60 1.1×	27 0.7×	47 1.5×	35 1.2×	19	326
Tongzhou Liang China	9	149 1.0×	44 0.8×	45 1.2×	37 1.2×	29 1.0×	20	358
Sameeksha Chopra Canada	7	168 1.2×	87 1.6×	32 0.8×	31 1.0×	21 0.7×	11	438
Tzuen Yih Saw Singapore	10	250 1.7×	44 0.8×	15 0.4×	44 1.4×	35 1.2×	13	461
Yuan Chang-ji China	9	250 1.7×	65 1.2×	21 0.5×	35 1.1×	24 0.8×	19	450
Elisa Vähäkangas Finland	7	266 1.8×	42 0.8×	25 0.6×	90 2.9×	26 0.9×	9	433
Yufeng Zhu China	9	225 1.6×	53 1.0×	61 1.6×	30 1.0×	22 0.8×	13	354

Countries citing papers authored by Fei-Xiang Lin

Since Specialization

Citations

This map shows the geographic impact of Fei-Xiang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei-Xiang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei-Xiang Lin more than expected).

Fields of papers citing papers by Fei-Xiang Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei-Xiang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei-Xiang Lin. The network helps show where Fei-Xiang Lin may publish in the future.

Co-authorship network of co-authors of Fei-Xiang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Fei-Xiang Lin. A scholar is included among the top collaborators of Fei-Xiang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei-Xiang Lin. Fei-Xiang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lin, Fei-Xiang, et al.. (2025). Nrf2 signaling pathway: focus on oxidative stress in osteoporosis. Osteoporosis International. 36(10). 1837–1854.

Lin, Fei-Xiang, et al.. (2024). MAPK signaling pathway in spinal cord injury: Mechanisms and therapeutic potential. Experimental Neurology. 383. 115043–115043. 16 indexed citations

Lü, Zhijun, et al.. (2024). Low frequency‑pulsed electromagnetic fields promote osteogenic differentiation of bone marrow‑derived mesenchymal stem cells by regulating connexin 43 expression. Experimental and Therapeutic Medicine. 28(6). 446–446.

Lü, Zhijun, et al.. (2024). Epigenetic modifications of inflammation in spinal cord injury. Biomedicine & Pharmacotherapy. 179. 117306–117306. 3 indexed citations

Lin, Fei-Xiang, et al.. (2023). Targeted Therapy of Spinal Cord Injury: Inhibition of Apoptosis Is a Promising Therapeutic Strategy. Molecular Neurobiology. 61(7). 4222–4239. 16 indexed citations

Lin, Fei-Xiang, et al.. (2023). The Role of Resveratrol on Spinal Cord Injury: from Bench to Bedside. Molecular Neurobiology. 61(1). 104–119. 4 indexed citations

Lin, Fei-Xiang, et al.. (2021). The role of aquaporin 4 (AQP4) in spinal cord injury. Biomedicine & Pharmacotherapy. 145. 112384–112384. 23 indexed citations

Wang, Hong, et al.. (2021). Preparation of total saponins from Panax japonicus and their protective effects on learning and memory ability of aging mice. Food Science and Technology. 42. 1 indexed citations

Wang, Hong, Zhihan Zhu, Guilong Zhang, et al.. (2019). AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy. Journal of Pharmaceutical Sciences. 108(11). 3684–3694. 34 indexed citations

10.

Lin, Fei-Xiang, Bo-Jui Chang, Qihao Zhang, et al.. (2018). Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways. Cellular Physiology and Biochemistry. 47(1). 161–175. 37 indexed citations

11.

Zhang, Qihao, Shi‐xin Du, Bo-Jui Chang, et al.. (2018). Reliability, Validity, and Responsiveness of the Chinese Version of the Knee Injury and Osteoarthritis Outcome Score (KOOS) in Patients with Anterior Cruciate Ligament Reconstruction in Mainland China. Zeitschrift für Orthopädie und Unfallchirurgie. 157(1). 42–47. 6 indexed citations

12.

Li, Xuedong, Peng Xie, Fei-Xiang Lin, et al.. (2017). All-trans-retinoic acid activates SDF-1/CXCR4/ROCK2 signaling pathway to inhibit chondrogenesis.. PubMed. 9(5). 2296–2305. 9 indexed citations

13.

Xie, Da, Peng Xie, Qihao Zhang, et al.. (2017). Antitumor activity of resveratrol against human osteosarcoma cells: a key role of Cx43 and Wnt/β-catenin signaling pathway. Oncotarget. 8(67). 111419–111432. 40 indexed citations

14.

Yu, Guoyong, Bo-Jui Chang, Fei-Xiang Lin, et al.. (2016). Naringin Stimulates Osteogenic Differentiation of Rat Bone Marrow Stromal Cells via Activation of the Notch Signaling Pathway. Stem Cells International. 2016(1). 7130653–7130653. 41 indexed citations

15.

Zheng, Gang, et al.. (2016). Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. European Journal of Cancer Care. 26(6). e12541–e12541. 30 indexed citations

16.

Lin, Fei-Xiang, Shi‐xin Du, Dezhong Liu, et al.. (2016). Naringin promotes osteogenic differentiation of bone marrow stromal cells by up-regulating Foxc2 expression via the IHH signaling pathway.. PubMed. 8(11). 5098–5107. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact